tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market

Compare Anbio Biotechnology Class A (NNNN) vs. Competitors

Compare
57 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Anbio Biotechnology Class A
$22.59
$3.15B
390.19
279.72%
Merit Medical Systems
$81.09
$4.81B
41.77
-26.48%
7 Buy
1 Hold
0 Sell
Strong Buy
Repligen
$149.37
$8.41B
5,880.16
-10.84%
6 Buy
0 Hold
0 Sell
Strong Buy
Teleflex
$104.37
$4.61B
-14.05
-42.92%
2 Buy
4 Hold
1 Sell
Hold
Stevanato Group
$15.58
$4.25B
27.39
-28.96%
2 Buy
1 Hold
0 Sell
Moderate Buy
Bausch + Lomb Corporation
$16.70
$5.91B
-19.41
-5.38%
4 Buy
5 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NNNN
Anbio Biotechnology Class A
21.91
16.24
286.42%
MMSI
Merit Medical Systems
81.09
-26.18
-24.41%
RGEN
Repligen
149.37
-10.50
-6.57%
TFX
Teleflex
104.37
-68.80
-39.73%
STVN
Stevanato Group
15.58
-6.54
-29.56%
BLCO
Bausch + Lomb Corporation
16.70
-0.75
-4.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts